(725914), N. A., (14151348), M. I., (14151351), J. M. J., (14151354), H. M. E., (14151357), A. A., (14151360), M. R., . . . (715733), F. M. (2022). Empagliflozin inhibits angiotensin II-induced hypertrophy in H9c2 cardiomyoblasts through inhibition of NHE1 expression.
Chicago Style (17th ed.) Citation(725914), Nabeel Abdulrahman, et al. Empagliflozin Inhibits Angiotensin II-induced Hypertrophy in H9c2 Cardiomyoblasts Through Inhibition of NHE1 Expression. 2022.
MLA (9th ed.) Citation(725914), Nabeel Abdulrahman, et al. Empagliflozin Inhibits Angiotensin II-induced Hypertrophy in H9c2 Cardiomyoblasts Through Inhibition of NHE1 Expression. 2022.
Warning: These citations may not always be 100% accurate.